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This study was designed to determine the reasons for the variability of the incidence of
congenital heart disease (CHD), estimate its true value and provide data about the incidence
of specific major forms of CHD. The incidence of CHD in different studies varies from about
4/1,000 to 50/1,000 live births. The relative frequency of different major forms of CHD also
differs greatly from study to study. In addition, another 20/1,000 live births have bicuspid
aortic valves, isolated anomalous lobar pulmonary veins or a silent patent ductus arteriosus.
The incidences reported in 62 studies published after 1955 were examined. Attention was
paid to the ways in which the studies were conducted, with special reference to the increased
use of echocardiography in the neonatal nursery. The total incidence of CHD was related to
the relative frequency of ventricular septal defects (VSDs), the most common type of CHD.
The incidences of individual major forms of CHD were determined from 44 studies. The
incidence of CHD depends primarily on the number of small VSDs included in the series,
and this number in turn depends upon how early the diagnosis is made. If major forms of
CHD are stratified into trivial, moderate and severe categories, the variation in incidence
depends mainly on the number of trivial lesions included. The incidence of moderate and
severe forms of CHD is about 6/1,000 live births (19/1,000 live births if the potentially
serious bicuspid aortic valve is included), and of all forms increases to 75/1,000 live births if
tiny muscular VSDs present at birth and other trivial lesions are included. Given the causes
of variation, there is no evidence for differences in incidence in different countries or
times. (J Am Coll Cardiol 2002;39:1890–900) © 2002 by the American College of
Cardiology Foundation
The number of adults with some form of congenital heart
disease (CHD) is growing rapidly as therapy becomes
increasingly effective. Some of these patients have only mild
disease with relatively little need for medical care, but others
have complicated problems and require the services of an
array of people with great expertise in the field. To assess the
needs for care for these patients, we need first to determine
the incidence of CHD as a group and of the individual
major congenital heart lesions. This determination is usually
incomplete, and there is substantial variation in the esti-
mated incidence of CHD. The reasons for this variation will
be examined and the current best estimates for incidence
will be provided.
DEFINITIONS
Incidence refers to the number of new affected persons per
unit of time or population; prevalence refers to the number
present at any time and represents the difference between
the incidence and those who die in the same period. The
incidence of CHD is usually estimated by calculating the
number of subjects with CHD per thousand or per million
live births. Sometimes these numbers are collected in a
region over one year, but at other times the data for several
years may be combined. For some purposes it is useful to
calculate the incidence in a country per year. Congenital
heart disease, in a definition proposed by Mitchell et al. (1),
is “a gross structural abnormality of the heart or intratho-
racic great vessels that is actually or potentially of functional
significance.” This definition excludes functionless abnor-
malities of the great veins, such as persistent left superior
cava (even though this might be important during surgery),
or of the branches of the aortic arch such as a combined
brachiocephalic-left carotid arterial trunk. It usually ex-
cludes congenital arrhythmias such as the long QT and the
Wolf-Parkinson-White syndromes, even if the disorders are
based on abnormalities present at birth. Lesions such as
hypertrophic or dilated cardiomyopathy are usually not
regarded as CHD. Even though the abnormal genes that
cause these disorders are present at birth, the cardiomyop-
athy is rarely detected at this time but usually presents later
in childhood or adolescence. Another genetically deter-
mined lesion, Marfan syndrome, is often included as CHD
because the phenotype may be present at birth, although
because the cardiac and aortic lesions may not appear for
many years not all studies include this syndrome.
INCIDENCE
Studies of the incidence of CHD usually estimate the total
incidence and the proportions of different CHDs, but
occasionally one or the other result is reported alone. The
medical equivalent of Heisenberg’s uncertainty principle is
involved, inasmuch as very large studies of huge populations
give sufficiently large numerators (live births) at the expense
of not being able to detect all with CHD (denominator),
whereas very intensive studies that find virtually all those
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with CHD in a region cannot be done on very large
populations. The former studies are usually passive, in that
diagnosis is made in a large regional high-quality pediatric
cardiology center but relies on referral of patients from local
doctors. Thus, if a local physician is comfortable with the
management of a tiny ventricular septal defect (VSD) or a
mild pulmonic stenosis (PS), that patient might not be
referred to a center and so not be counted. In addition, some
lesions with subtle physical findings, such as atrial septal
defects (ASDs), might not be detected until they appear in
adult life (2,3). Finally, some neonates with severe critical
heart disease may die in the first few days after birth, and
without cardiologic or autopsy diagnosis would not be
correctly identified (4,5). On the other hand, the more
intensive studies, for example, of all neonates in a nursery,
will detect all forms of CHD and allow for early deaths, but
the incidence of uncommon forms of CHD will be inade-
quately assessed because of small numbers and stochastic
variation.
Early studies of the incidence of CHD, as summarized by
Hoffman (6) produced low incidences of about 4 to 5 per
1,000 live births, but this figure has been rising steadily until
recently when incidences of 12 to 14/1,000 live births, or
higher, have been reported in the literature (7) (Fig. 1)
(1,8–67) as well as by P. Merlob (personal communication,
June 2000).
Among the reasons for the early lower incidence rates of
4 to 5/1,000 live births is that only the most severely affected
subjects were referred to a cardiac center, that there was
relatively little interest in and knowledge of CHD by
pediatricians and that cardiac surgery had not yet offered the
spectacular results that now demand referral of these pa-
tients. Furthermore, before the availability of good echocar-
diography, diagnosis if not certain clinically had to be
established by cardiac catheterization, and many doctors
were reluctant to catheterize what was obviously a mild
defect.
What accounts for the differences in incidence in the
more recent studies? There are many reasons for a low
incidence. A few studies were restricted to infancy (25) and
so missed some patients who present later in life (68).
Several of the later studies (51,54,67) based their data on the
results of fetal echocardiography in unselected populations.
These studies will not detect patients with a small ventric-
ular or ASD, an abnormal patent ductus arteriosus (PDA)
or many with coarctation of the aorta (Coarc). The increas-
ing use of fetal echocardiography also leads in certain
communities to therapeutic abortion for complex heart
diseases, and can substantially reduce the incidence of
specific lesions (69) or the total incidence (70). Some studies
deliberately (15) excluded trivial lesions such as mild PS.
Studies that cover a large region but rely on local physicians
to refer patients will tend to underestimate the number of
trivial lesions in the community (20,24,30,66). By contrast,
high incidences were found in those studies that examined
all or almost all newborn infants in a region, because they
detected large numbers of small VSDs and other trivial
Abbreviations and Acronyms
AS  aortic stenosis
ASD  atrial septal defect
AVSD  atrioventricular septal defect
BAV  bicuspid aortic valve
CHD  congenital heart disease
Coarc  coarctation of the aorta
DORV  double outlet right ventricle
NERICP  New England Regional Infant Cardiac
Program
PDA  patent ductus arteriosus
PS  pulmonic stenosis
SV  single ventricle
VSD  ventricular septal defect
Figure 1. Histogram of the incidence of congenital heart disease per 1,000 live births in 62 reports. The six highest values all came from echocardiographic
studies of infants in the newborn nursery.
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lesions (37,40,48). Therefore, any assessment of the inci-
dence of CHD must take into account the ages of the
patients and the ways in which they entered the study. It is
important to note that none of the studies analyzed included
bicuspid aortic valves (BAVs), isolated lobar anomalous
pulmonary venous connection or silent PDA, with respec-
tive incidences of about 13, 6 and 1 per 1,000 live births (to
be described). If these are to be included, the incidences
depicted in Figure 1 should be increased by 20/1,000 live
births.
Today, clinical and echocardiographic diagnoses are so
accurate that few misdiagnoses are made, but there remain
important diagnostic problems of classification and, there-
fore, of inclusion as specific lesions. These problems vary by
lesion and will be addressed briefly.
Isolated VSDs are by far the most common form of CHD.
Some studies done by taking echocardiograms on every
newborn infant in a nursery, including some with no
murmurs, have found huge numbers of tiny muscular VSDs,
the incidence of these varying from 2% to 5% (48,62).
About 85% to 90% of these defects close spontaneously by
one year of age (37,48,71–73). Therefore, the incidence of
VSD will be much higher if all newborns are examined,
lower if only those newborns with murmurs are examined
and lower still if accession of these subjects is delayed until
one year of age. Although these small defects that close
spontaneously place little burden on the health care system,
correct identification of their incidence has a possible
bearing on studies of causation.
Patent ductus arteriosus is another common lesion, the
incidence of which varies with the age at the time of study
and the gestational age of the subject. Preterm infants have
an increased incidence of PDA based on abnormal physi-
ology rather than on a structural abnormality, so that any
series that includes large numbers of preterm infants will
inflate the incidence of PDA (74). In term infants the
normal ductus may stay open for some time after birth.
Scammon and Norris (75) found in autopsy studies that the
ductus arteriosus was completely obliterated in 35% of
subjects by one month, in 75% by three months and in
virtually all by one year after birth. It is known, however,
that functional closure precedes obliteration, often by a long
time. Mitchell (76) observed in an autopsy study that no
ductuses were widely patent after one week and that
virtually all were closed by one month after birth. More
recently, sensitive studies based on echocardiography (77–
79) have shown that in the term infant the ductus arteriosus
is almost always closed by four to seven days after birth.
Therefore, studies done a few days after birth will record a
larger number of subjects with a PDA than will studies done
after three weeks (71). Recently some attention has been
paid to the silent ductus arteriosus, a tiny ductus that is not
detected by auscultation but found incidentally during
echocardiography done for some other purpose. These may
be common; estimates of 1 per 500 to 1,000 population have
been given (80). These silent ductuses are not included in
any current incidence surveys.
Atrical septal defects of the fossa ovalis (secundum) type also
give many problems of classification and diagnosis. Many
infants have a patent foramen ovale with a tiny left-to-right
shunt through it, and inclusion of these will inflate the
incidence of ASD. Even if the patent foramen ovale is
excluded, for example, by diagnosing ASD only when the
defect is over 5 mm in diameter and the right atrium or
ventricle are dilated (71), there appears to be a higher early
spontaneous closure rate than has hitherto been appreciated
(71,81–84). Once again, as for VSDs, the timing of the
study and the population studied (all infants vs. those with
murmurs or symptoms) influence the incidence attained.
Furthermore, because an ASD is usually asymptomatic and
has murmurs that are often soft, these defects frequently do
not lead to early diagnosis or referral. This is why many of
these subjects present in adult life (2,3), so the incidence in
childhood usually underestimates the true incidence of the
lesion.
Isolated partial anomalous pulmonary venous connection is a
rare lesion clinically, and it resembles an ASD in producing
a right ventricular volume overload. Some studies, however,
have shown an incidence of 0.6% to 0.7% in routine
autopsies (85,86), implying that most of these are small
shunts of little clinical significance. This lesion is reported
rarely in reports of the incidence of CHD and its apparent
high incidence does not feature in incidence studies dis-
cussed here.
Atrioventricular septal defects (AVSDs) (endocardial cush-
ion defects, common atrioventricular canal) have an inci-
dence that varies with the age of the involved mothers.
Trisomy 21 (Down syndrome) is much more common in
mothers more than 34 years old, and AVSDs are much
more frequent in those with trisomy 21 than with normal
chromosomes. Thus, the proportion of older mothers in a
series greatly increases the incidence of AVSDs. Because
therapeutic abortions may be performed if trisomy 21 is
discovered early in pregnancy, the incidence of AVSD at
term is likely to decrease in future years.
Pulmonic stenosis if mild is often confused with an
innocent pulmonic flow murmur. In fact, in our own
incidence study (16), done before extensive use of echocar-
diography, this was our single greatest diagnostic difficulty.
Various discriminatory standards have been used to diag-
nose this anomaly. Bound and Logan (15) diagnosed PS
only if the systolic gradient across the valve at cardiac
catheterization exceeded 25 mm Hg. More recently, using
echocardiography, a flow velocity over 120 cm/s was used to
decide if a newborn infant had PS (71). Pulmonic stenosis
is another lesion in which the incidence changes with
follow-up. Stenosis with thickened valves in the neonate can
resolve with time and leave a normal valve, as described first
by Johnson et al. (cited by Gielen et al. [87]); we have since
observed several patients with this course. On the other
hand, some subjects with very mild PS in the neonatal
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period (who might not be included as PS in any series)
might develop more severe PS with time (88–90).
Aortic stenosis (AS), if moderate or severe, is usually easy to
diagnose, but when mild causes many problems. Many
cardiologists distinguish between AS, in which there is a
pressure gradient across the valve, and a bicuspid valve that
is nonobstructive. Unfortunately, no accepted criteria for
this distinction have been developed. Ooshima et al. (71)
used the criterion of a flow velocity in the ascending aorta in
newborns over 160 cm/s as indicating stenosis. Kitchiner et
al. (91) diagnosed AS in children if the flow velocity in the
ascending aorta exceeded 2 m/s or the peak systolic pressure
gradient at cardiac catheterization exceeded 10 mm Hg.
Because a nonstenotic BAV is thought to occur in about 1%
of all live births (to be discussed), inclusion of a significant
number of these as AS will inflate the incidence of this
lesion.
Bicuspid aortic valves are important because of their
frequency and their late complications. Most subjects with
BAVs develop stenosis or incompetence after 40 years of
age, and so they are not usually recorded in the other studies
of incidence in pediatric populations cited in this article.
Instead they have been studied as independent lesions. The
standard for their detection is the postmortem examination
done on unselected consecutive necropsies. There is some
variation in incidence from about 0.4% to 2.25%. There are
studies with incidences of 0.44% to 0.77% (92–97) that
probably underestimate the true incidence, because these
studies usually excluded subjects with other forms of heart
disease or even with true stenosis or incompetence. Other
studies give incidences of 0.9% to 2.25% (98–102). The
high figure of 2.25% from Osler (98) might exaggerate the
incidence because 8 of his 18 patients had infective endo-
carditis. The best single figure is 1.37% by Larson and
Edwards (102) because of the large numbers seen (293
BAVs in 21,417 autopsies) and the expertise of the inves-
tigators in assessing abnormal aortic valves.
Coarctation of the aorta is an abnormality easily diagnosed
by the combination of upper body hypertension and weak or
absent femoral pulses. Nevertheless, studies in children’s
hospitals have shown that the diagnosis is often missed by
the referring doctor (103–105), with little improvement
over the past 20 years. If this is true for symptomatic
children, it may be even more serious in asymptomatic
subjects. As a consequence, many subjects with a Coarc are
not detected until adult life, so that their incidence at birth
is likely to be underestimated.
Mitral incompetence as an isolated congenital lesion is rare
in children, and usually not recorded separately in most
reported series. On the other hand, mitral valve prolapse,
although rare in the newborn period, is common, occurring
in perhaps 4% to 5% of the population (106–108). Inclusion
of any of these as true congenital lesions inflates the
incidence of CHD.
There is inconsistency in how multiple lesions are classi-
fied. For example, a VSD with a Coarc may be classified in
a separate category, it may be classified under the heading
“Coarc” if the VSD is small, or as “VSD” if this seems to be
the major lesion, and sometimes it is classified under the
heading of complex lesions or just placed in a miscellaneous
category. Some investigators use the miscellaneous category
to include lesions too rare to deserve separate mention, for
examples, anomalous origin of the coronary artery, partial
anomalous pulmonary venous connection with an intact
atrial septum, isolated cleft mitral valve, congenital endo-
cardial fibroelastosis, l-transposition of the great arteries, cor
triatriatum and so on. This category, however, sometimes
includes slightly more common lesions such as truncus
arteriosus, double outlet right ventricle (DORV) or single
ventricle (SV) that in other series are separated out. Because
of the varied composition of this category, it is not compa-
rable from series to series.
CATEGORIES OF SEVERITY
If we consider which groups of patients with CHD use
health care services, there will be obvious differences be-
tween the serious lesions like tetralogy of Fallot and AVSDs
and those such as small VSDs. The same distinction by
category also applies to studies of incidence, inasmuch as it
is the least severe lesions that account for most of the
differences between various studies. For example, two stud-
ies (30,66) documented that the increase in the incidence of
CHD with time was due solely to the increase in the
incidence of mild forms of heart disease. It is therefore
useful to grade CHD into three groups of lesions and to
consider their incidences separately. The following classifi-
cation is similar in many ways to those published previously
(109,110), except that late complications and the effects of
surgery are not included here.
1. Severe CHD
This category includes the majority of the patients who
present as severely ill in the newborn period or early
infancy. Some of these patients who die very early might
not be included in studies that do not track every infant
born.
A. All those with cyanotic heart disease
1. d-transposition of the great arteries
2. Tetralogy of Fallot, including pulmonary atresia
and absent pulmonary valve
3. Hypoplastic right heart
a. Tricuspid atresia
b. Pulmonary atresia with an intact ventricular
septum
c. Ebstein anomaly
4. Hypoplastic left heart
a. Aortic atresia
b. Mitral atresia
5. SV
6. DORV
7. Truncus arteriosus
8. Total anomalous pulmonary venous connection
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9. Critical PS
10. Miscellaneous uncommon lesions like double out-
let left ventricle, certain unusual malpositions and
some forms of l-transposition of the great arteries.
B. Acyanotic lesions
1. AVSD
2. Large VSD
3. Large PDA
4. Critical or severe AS
5. Severe PS
6. Critical Coarc
2. Moderate CHD
These require expert care, but less intensive than those
listed above. Most of these are expected to be detected in
a clinical study. They include:
A. Mild or moderate AS or aortic incompetence
B. Moderate PS or incompetence
C. Noncritical Coarc
D. Large ASD
E. Complex forms of VSD
3. Mild CHD
This is the most numerous group. Because these patients
are asymptomatic, may not have significant murmurs and
often undergo early spontaneous resolution of their
lesions, inclusion of more or fewer of this group greatly
influences the resulting observed incidence of CHD.
A. Small VSD
B. Small PDA
C. Mild PS
D. BAV without AS or aortic incompetence; these may
move to moderate or severe categories if they deteri-
orate with age
E. Small or spontaneously closed ASD
It is probable that most of the patients in the severe and
moderate groups will be detected in any good medical
system, and that the lesions that are the major causes of
variability appear in the mild group. Because VSDs have
long been recognized as the most frequent isolated forms of
CHD, their number will greatly influence the total inci-
dence of CHD. This is shown in Figure 2, where the
incidence of CHD (excluding BAVs without AS or incom-
petence) and the percentage of VSDs reported in the more
modern studies plotted against the final year of the study in
the left and center panels, and the incidence of VSDs is
plotted against the incidence of CHD in the right panel.
The final year was chosen as an indication of the technology
available for the study, and choosing the mid-year of the
study did not affect the results. Studies were included if they
ended in or after 1955 so as to include only studies done
when cardiac catheterization was becoming a common
diagnostic test. The horizontal lines are drawn arbitrarily at
10/1,000 live births (left and right panels) and 40% in the
center panel. The vertical lines are drawn arbitrarily at 1985
in the left and center panels and at 40% in the right panel.
It is clear from the left panel that after 1985 an increasing
number of studies reported an incidence over 10/1,000 live
births; this incidence was exceeded by only 1/24 studies
ending before 1985, but by 17/38 studies ending at or after
1985 (p  0.0039 by Fisher exact test). Because VSDs have
always been the single most frequently reported lesion, their
proportion of all CHD was examined in the center panel. In
studies ending before 1985, only 3/20 studies had over 40%
of VSDs, whereas this percentage was exceeded by 20/34
studies ending after 1985 (p  0.0016 by Fisher exact test).
This explains why in the right panel in which the percentage
of VSDs is plotted against the incidence of CHD, inci-
dences of over 10/1,000 live births were reported in only
5/30 studies with under 40% VSDs but in 11/24 studies
with more than 40% of these defects (p  0.021 by Fisher
exact test). These differences still appear if the six studies of
neonates with very high proportions of VSDs are excluded.
The principal reason for this increase in incidence of
CHD and of VSDs after 1985 was the inclusion of more
small VSDs with the increasing use of echocardiography. In
fact, several investigators noted the increased incidence of
small VSDs in the later years of their studies
(11,30,33,40,42,49,111–113). The relationship between the
incidence of VSD and the total incidence of CHD is shown
more directly in the left panel of Figure 3. The slope of the
Figure 2. The incidence of congenital heart disease (CHD) per 1,000 live births is plotted against the final year of the study (left) and against the percentage
of ventricular septal defects (VSDs) (right). In the center, the percentage of VSDs is plotted against the final year of the study. The horizontal lines are
drawn arbitrarily at an incidence of 10/1,000 live births and 40% of all CHD, and the vertical lines are drawn arbitrarily at 1985 and 40%, respectively.
An increasing proportion of the high incidences are beyond 1985 and for series that have over 40% VSDs.
1894 Hoffman and Kaplan JACC Vol. 39, No. 12, 2002
Incidence of CHD June 19, 2002:1890–900
relationship of VSDs to total CHD is 1.9, showing that the
total incidence rises faster than the incidence of VSDs. This
is shown directly in the center panel of Figure 3, where the
incidence of VSDs is plotted against the total incidence of
all other forms of CHD. The significant positive slope of
0.9 shows clearly that as the incidence of ventricular defects
increases, so does the total incidence of all forms of CHD.
The likely mechanism of this positive relationship is that
those studies that detect the small VSDs are intensive
enough to detect more of the other mild forms of CHD.
The right panel in Figure 3 provides data to support this
contention by showing that the incidence of all cyanotic
heart diseases, a surrogate for all serious CHD, rose little
(slope 0.14) as the incidence of VSDs increased. These
cyanotic diseases are always major and are usually detected
even without intensive studies, so that adding universal
neonatal echocardiography does little to increase their de-
tection.
Another way of analyzing incidences is to examine the
variability (expressed as median and interquartile distance)
for total CHD, VSDs and the remainder when all VSDs are
taken away from total CHD and cyanotic heart diseases
taken as a group. The results are shown in Figure 4.
Although there are more total patients in the remainder
(that is, all CHD without the VSDs) than for VSDs or
cyanotic heart disease, the remainder has a smaller variabil-
ity than the total group or the VSDs, and the cyanotic group
has the least variability.
Given the uncertainties of estimating incidence, there is
no evidence that the true incidence of CHD has changed
over the past 50 years, or that it varies in different countries.
Several studies have shown, however, that the diagnosed
incidence of CHD has increased over the years in a
particular region because of longer follow-up (47) or because
more subjects with mild lesions have been included (30,66).
On the other hand, because parents (particularly mothers)
with CHD have a higher incidence of children with CHD
(114–116), there is reason to believe that the incidence of
CHD will rise slowly in the years to come. Carter (117) has
estimated that the incidence will double in seven genera-
tions. Finally, the availability of therapeutic abortion for
complex cardiac lesions will decrease their incidence to an
unknown extent. In one population study (66), this factor
had a negligible effect on total incidence, but some other
studies suggest that therapeutic abortions substantially re-
duce the incidence of CHD in live births (118,119).
INCIDENCES OF SPECIFIC LESIONS
The data are presented in Table 1 and Figure 5; both of
these emphasize the dominant role played by VSDs. They
are taken from 44 published studies of the incidence of
CHD in which there were at least 100 subjects with cardiac
lesions and in which the lesions were not almost all tiny
muscular VSDs found in the neonatal nursery (1,9,11–
Figure 3. The incidence of ventricular septal defects (VSDs) on the horizontal axis is plotted against the total incidence of all congenital heart disease
(CHD) in the left panel, against the incidence of the remainder of CHD (that is, all CHD except for VSD) in the center panel, and against the incidence
of all cyanotic CHDs in the right panel (all incidences/million live births).
Figure 4. Modified box plots to show variability of the incidence per
million live births of total congenital heart disease (CHD), ventricular
septal defects (VSDs), the remainder of CHD (total minus VSD) and all
cyanotic CHD. The plots were made with StatView 5 (SAS Institute Inc.,
Cary, North Carolina). In them, the rectangle shows the upper and lower
quartiles and the horizontal line in the middle is the median. The two
short horizontal lines connected to the rectangle by thin vertical lines
indicate the 90th and 10th percentiles, and data points outside these limits
are shown individually.
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13,15–17,20 –22,24 –26,28 –31,34 –36,38 – 42,46,47,49,50,
53–55,57,58,62–67,84,120), as well as one personal com-
munication (Merlob P, et al., June 2000).
If all the studies were unbiased and equally intensive, then
the median value would give an excellent estimate of the
incidence of that lesion at birth. However, some of these
studies underestimated the incidence of a particular lesion
by omitting mild disease or early spontaneous cure (such as
PS, VSD), or by not having representatives of certain lesions
with low frequencies in a small series, and others overem-
phasized the insignificant lesions by doing echocardiograms
on every newborn infant. Because the value of the median is
affected by the number of small or large outliers rather than
by their magnitude, and because there are probably more
studies that underestimated than overestimated incidence,
we have included the lower and upper quartiles for readers
to judge the variability. In our opinion, the upper quartile
might be the best single figure to represent the incidence at
birth of a particular congenital heart lesion. The mean and
standard deviations are also given as another indication of
the wide range and skewing of some of the data.
In 1980, Fyler et al. (121) reported the results of the New
England Regional Infant Care Program (NERICP). This
was based on a consortium of hospitals in New England that
pooled their data concerning ill infants admitted with heart
disease to one of the regional hospitals. For the period 1975
to 1977, the incidence of severe CHD was 2,033/million
live births, 888 of these being one of the cyanotic lesions
mentioned above, with another 200 to 300 possible cyanotic
lesions (Table 8 in reference 126). If we include these latter
lesions (mostly heterotaxies, critical PS, l-transposition of
the great arteries and miscellaneous lesions) the total of all
cyanotic lesions (the lesions most likely to be detected in any
series) in the NERICP data is between the lower quartile
and the median values in Table 1. To these are added those
with large VSDs, AVSD, the occasional ASD, critical
Coarc and AS, and some miscellaneous lesions. Because
most acyanotic lesions are relatively mild and thus not
included in the NERICP series, the total incidence of CHD
in their series refers only to the most severe disease.
Because of the inaccuracies in determining the incidence
of CHD, it is difficult to know whether differences from
study to study in the incidence of specific lesions are real or
merely methodological. Some of the differences in the
incidence of specific lesions, particularly the more common
acyanotic lesions, are due to the problems described earlier.
For the cyanotic lesions, their infrequency in any series leads
to statistical uncertainty. For example, if there are only 2
patients with a truncus arteriosus out of 10,000 live births,
for an apparent incidence rate of 200 per million live births,
Poisson statistics suggest that the 95% confidence limits for
this number are 0.242 to 7.22, equivalent to a range of 24 to
722/million live births. Failing to find a particular lesion in
a series of 100 patients with CHD is compatible with a 3%
incidence of that lesion, equivalent to an incidence of about
300/million live births!
Nevertheless, there are certain definite differences in the
incidence of some types of CHD in different populations.
The best documented of these is the excessively high
proportion of subarterial VSDs in China and Japan (about
Table 1. Incidence per Million Live Births
Lesion
Number
of Studies Mean SD
Lower
Quartile Median
Upper
Quartile
NERICP
1975–1977
VSD 43 3,570 2,878 1,757 2,829 4,482 345
PDA 40 799 1,399 324 567 782 135
ASD 43 941 1,043 372 564 1,059 65
AVSD 40 348 165 242 340 396 110
PS 39 729 731 355 532 836 73
AS 37 401 543 161 256 388 41
Coarc 39 409 246 289 356 492 165
Tetralogy 41 421 188 291 356 577 196
d-TGA 41 315 115 231 303 388 218
HRH 32 222 199 105 160 224 —
Tricuspid atresia 11 79 52 24 92 118 56
Ebstein’s anomaly 5 114 138 38 40 161 12
Pul Atresia 11 132 123 76 83 147 69
HLH 36 266 216 154 226 279 163
Truncus 30 107 71 61 94 136 30
DORV 16 157 103 82 127 245 32
SV 23 106 70 54 85 136 54
TAPVC 25 94 46 60 91 120 58
All cyanotic 37 1,391 590 1,078 1,270 1,533 888
All CHD* 43 9,596 7,484 6,020 7,669 10,567 2,033
BAV 10 13,556 13,049 5,336 9,244 13,817 —
*Excluding bicuspid nonstenotic aortic valves, isolated partial anomalous pulmonary venous connection and silent ductus
arteriosus.
BAV bicuspid aortic valve; CHD  congenital heart disease; Coarc  coarctation of the aorta; NERICP  New England
Regional Infant Cardiac Program. Other abbreviations as in legend to Figure 5.
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35% vs. 5% in Caucasians (122,123). There are also indi-
cations of an excessive incidence of tetralogy of Fallot and
other forms of right ventricular outflow tract obstruction in
Malta (55,124), and Fixler et al. (30) observed that AS and
Coarc were more common in Caucasians than in the black
or Hispanic population.
CONCLUSIONS
The variations in the reported incidence of CHD are
primarily due to variations in the ability to detect trivial
lesions, notably small muscular VSDs that usually close in
infancy. The incidence of severe CHD that will require
expert cardiologic care is quite stable at about 2.5 to 3/1,000
live births. The moderately severe forms of CHD probably
account for another 3 per 1,000 live births, although another
13/1,000 live births have BAVs that will also eventually need
cardiologic care. The majority of minor forms of CHD do not
need specialized cardiologic care, and indeed many of these,
such as the tiny VSD or ASD and the small PDA, may either
close spontaneously or never cause medical problems.
Reprint requests and correspondence: Dr. Julien I. E. Hoffman,
Box 0544, Room M1331, University of California, 505 Parnassus
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Figure 5. Modified box plots made in StatView 5; description as for Figure 4. Each panel has a different vertical scale, that on the top panel being 10 times
larger than that on the bottom panel. (Top) The four major left-to-right shunts (ventricular septal defect [VSD]; patent ductus arteriosus [PDA]; atrial
septal defect [ASD]; atrioventricular septal defect [AVSD]) and the three major obstructive lesions (pulmonic stenosis [PS]; aortic stenosis [AS]; coarctation
of the aorta [Coarctation]). (Bottom) Tetralogy of Fallot (Tetralogy); complete transposition of the great arteries (d-TGA); hypoplastic right heart (HRH),
which includes tricuspid atresia, Ebstein’s anomaly, and pulmonary atresia with an intact ventricular septum (pul atresia IVS); hypoplastic left heart (HLH);
truncus arteriosus (Truncus); double outlet right ventricle (DORV); single ventricle (SV); total anomalous pulmonary venous connection (TAPVC). The
three components of the HRH syndrome do not add up to the total, because not all reports included all three.
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